National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
17Maximum number of repeats—related pharmaceutical benefits
Start here
Get a plain-English read of 17
Turn the raw legal text into a practical explanation grounded in National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
17 Maximum number of repeats—related pharmaceutical benefits
(1) For the purposes of paragraph 85A(2)(b) of the Act, this section determines the maximum number of occasions an authorised prescriber may, in one prescription, direct that a special arrangement supply of a related pharmaceutical benefit be repeated. (2) If only one number is mentioned in the column of the table in Schedule 2 headed “Number of Repeats” in relation to the related pharmaceutical benefit, that number is the maximum number of occasions for all purposes. (3) If more than one number is mentioned in the column of the table in Schedule 2 headed “Number of Repeats” in relation to the related pharmaceutical benefit, then: (a) if a purposes code is mentioned in the column of the table headed “Purposes” in relation to a number—that number is the maximum number of occasions for the purposes mentioned in the table in Part 1 of Schedule 3 for that purposes code; and (b) if no purposes code is mentioned in the column in relation to a number—that number is the maximum number of occasions for all purposes other than purposes to which paragraph (a) applies. Application of this section (4) To the extent that this section provides for a matter not provided for in the Listing Instrument, this section applies in addition to the Listing Instrument. (5) To the extent that this section makes a different provision for a matter provided for in the Listing Instrument, this section applies despite the Listing Instrument.